4//SEC Filing
Treace John T. 4
Accession 0000950170-25-008971
CIK 0001630627other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 9:30 PM ET
Size
8.4 KB
Accession
0000950170-25-008971
Insider Transaction Report
Form 4
Treace John T.
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Stock
2025-01-22+225,000→ 6,736,190 total
Holdings
- 1,605,000(indirect: By Spouse)
Common Stock
- 1,839,063(indirect: By Trust)
Common Stock
- 1,471,250(indirect: By Trust)
Common Stock
- 408,816(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date.
- [F2]Includes 437,536 restricted stock units
- [F3]The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee
- [F4]The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001856380
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 9:30 PM ET
- Size
- 8.4 KB